Showing results (321-330 of 608) with videos related to

Sort By:
Pageof 61
Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United StatesXuehua Ke, Abhishek Kavati, Debra Wertz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2015
Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background TherapyThomas B Casale, Jonathan A Bernstein, Marcus Maurer, et al.
Current Medical Research and Opinion|October 25, 2017
Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticariaLiya Wang, Xuehua Ke, Abhishek Kavati, et al.
Allergy|May 26, 2025
Anti-KIT Barzolvolimab for Chronic Spontaneous UrticariaMarcus Maurer, Martin Metz, John Anderson, et al.
The World Allergy Organization Journal|November 16, 2013
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic RhinitisMichael A Kaliner, James N Baraniuk, Michael S Benninger, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2024
The Impact of Prior Authorization on Clinical Practice and Patient Care Outcomes: A Work Group Report of the AAAAI Prior Authorization Task ForceJonathan A Bernstein, Deepthi Gadde, Mohamed Yassin, et al.
Genome Biology|June 16, 2026
Ensilication preserves high-molecular weight native DNA for clinical long-read sequencingAlexis Ferrasse, Rodrigo Mendez, John E Gorzynski, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 12, 2023
Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysisWilliam Lumry, Timothy Craig, John Anderson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 24, 2020
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedemaJonathan A Bernstein, Lawrence Schwartz, William Yang, et al.
Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.
Pageof 61